Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Advanced polymer reverse phase chromatography ensures high purity thymalfasin. Reduces impurities significantly for reliable pharmaceutical intermediate supply chain stability.
Advanced aqueous synthesis of Miriplatin eliminates toxic solvents. Discover cost-effective manufacturing and high-purity supply chain solutions for oncology intermediates.
Novel polymer chromatography method reduces impurities to 0.01%. Ensures supply chain reliability and cost efficiency for pharmaceutical manufacturers.
Novel room-temperature crystallization process for Pemetrexed Disodium ensures high purity and stability. Ideal for reliable pemetrexed disodium supplier partnerships.
Patent CN103992391B details a surfactant-enhanced HPLC method removing toxic impurities, ensuring high-purity terlipressin for cost reduction in pharmaceutical manufacturing.
Patent CN110054553B details a novel chiral tetrabenzocyclooctatetraene-catalyzed method for high-purity ketone intermediates, offering significant cost and supply chain advantages.
Patent CN106187982A reveals green ionic liquid catalysis for high-purity xanthenedione. Enhances supply chain reliability and reduces manufacturing costs significantly.
Novel reduction method for dexpramipexole dihydrochloride. High purity, mild conditions, cost-effective API manufacturing solution.
Patent CN1019300B reveals a direct acylation method for 7-amino-cephalosporins using acid salts, offering superior purity and cost efficiency for pharmaceutical manufacturers.
Patent CN1019300B reveals a novel acylation method for cephalosporins using acid addition salts, offering high purity and simplified processing for reliable pharmaceutical intermediates supply.
Novel bicomponent catalyst method for benzimidazoles. High purity, scalable process reducing costs for pharmaceutical intermediate manufacturing supply chains.
Patent CN1019300B reveals stable amine salt acylation for high-yield cephalosporins, offering cost-effective supply chain solutions.
Patent CN113548999A details a novel Pd-catalyzed route to 3-(2,3-butadienyl)oxindoles with high enantioselectivity, offering cost-effective solutions for antiviral drug development.
Patent CN112321425B details a novel two-step one-pot synthesis for methyl 4-(3-bromopropyl) benzoate, offering significant cost reduction and scalability for osteoporosis drug intermediates.
Discover the patented aqueous synthesis method for Cilostazol (CN1257902C). Achieve >99% purity with reduced environmental impact and optimized manufacturing costs.
Patent CN85101840A details a novel stereoselective route for 16-phenoxy prostaglandin trienoic acid derivatives, offering improved crystallinity and supply chain reliability for pharmaceutical manufacturers.
Patent CN117343004A reveals mild catalyst-free route reducing cost and improving supply chain reliability for high-purity pharmaceutical intermediates globally.
Patent CN114277006B reveals a novel ADH for synthesizing chiral heterocyclic alcohols without organic solvents, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN102757356B details a cost-effective splitting process for D-HPG. Enhances supply chain reliability and reduces waste in API intermediate manufacturing significantly.
Novel S173Q/Q360Y mutant enzyme boosts D-alanine yield by 20% and stability 3-fold, offering cost-effective pharma intermediate solutions.